CD44 and breast carcinoma: Liu and colleagues isolated CSCs (using ESA+/CD24−/CD44+/lin− CSC and ESA+/CD24+/CD44−/lin− non-CSC markers) from six breast cancer tissue samples and identified any changes in the miRNAs by miRNA microarray [74].